This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ptc Therapeutics, Inc., Merck Sharp + Dohme Corp., Schering Corporation. Active years: 2003-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 186 
1 out of 2,405 
1 out of 1,829 
Years Active: 2003-2017
Title: The Innovations of Amin Nomeir: A Spotlight on His Contributions to Antiviral Treatments and Cancer Therapy
Introduction
Amin Nomeir, an accomplished inventor based in Milford, NJ, has made significant contributions to the fields of medicine and pharmaceuticals. With a total of four patents to his name, he has focused on developing innovative compounds and methods that promise advancements in antiviral treatments and cancer therapies.
Latest Patents
Among his most recent inventions, Nomeir has developed a series of patents aimed at combating viral infections and cancer. One notable patent, titled "Compounds and methods for antiviral treatment," introduces compounds and pharmaceutical compositions that effectively treat viral infections by modulating viral replication. This innovative work seeks to provide new avenues for managing viral diseases.
Another significant patent, "Substituted piperidines that increase p53 activity and the uses thereof," presents a compound designed to inhibit the HDM2 protein, along with pharmaceutical compositions that utilize these compounds. This invention holds the potential to aid in cancer treatment by enhancing p53 activity.
Career Highlights
Throughout his career, Amin Nomeir has been associated with reputable organizations where he applied his expertise in the pharmaceutical industry. He has worked with PTC Therapeutics, Inc. and Schering Corporation, contributing to advancements in drug development and innovation.
Collaborations
Nomeir's journey has allowed him to collaborate with esteemed colleagues in the field, including F George Njoroge and Guangming Chen. These partnerships have undoubtedly enriched his research and led to impactful innovations in the medical landscape.
Conclusion
Amin Nomeir's work exemplifies the essence of innovation in the pharmaceutical industry. His patents not only reflect his creative ingenuity but also his dedication to addressing critical health challenges. With ongoing advancements in his research, Nomeir continues to pave the way for future breakthroughs in antiviral and cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile